Revvity Inc (RVTY)
126.06
-0.28
(-0.22%)
USD |
NYSE |
Sep 27, 16:00
126.02
-0.04
(-0.03%)
Pre-Market: 20:00
Revvity Research and Development Expense (Annual): 216.58M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 216.58M |
| December 31, 2022 | 221.62M |
| December 31, 2021 | 200.34M |
| December 31, 2020 | 146.44M |
| December 31, 2019 | 189.34M |
| December 31, 2018 | 194.00M |
| December 31, 2017 | 139.46M |
| December 31, 2016 | 124.18M |
| December 31, 2015 | 112.54M |
| December 31, 2014 | 108.06M |
| December 31, 2013 | 132.40M |
| December 31, 2012 | 131.84M |
| December 31, 2011 | 115.82M |
| December 31, 2010 | 94.81M |
| Date | Value |
|---|---|
| December 31, 2009 | 90.78M |
| December 31, 2008 | 108.94M |
| December 31, 2007 | 111.62M |
| December 31, 2006 | 99.72M |
| December 31, 2005 | 87.37M |
| December 31, 2004 | 82.36M |
| December 31, 2003 | 83.14M |
| December 31, 2002 | 86.45M |
| December 31, 2001 | 81.32M |
| December 31, 2000 | 86.12M |
| December 31, 1999 | 71.20M |
| December 31, 1998 | 46.00M |
| December 31, 1997 | 44.50M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
146.44M
Minimum
2020
221.62M
Maximum
2022
194.86M
Average
200.34M
Median
2021
Research and Development Expense (Annual) Benchmarks
| Avantor Inc | -- |
| Agilent Technologies Inc | 481.00M |
| Bionano Genomics Inc | 54.03M |
| Bruker Corp | 294.80M |
| Azenta Inc | 33.96M |